↑Miyagi Y, Yasumitsu H, Mizushima H, Koshikawa N, Matsuda Y, Itoh H, Hori TA, Aoki I, Misugi K, Miyazaki K (Jan 1997). "Cloning of the cDNA encoding mouse PP5/TFPI-2 and mapping of the gene to chromosome 6". DNA Cell Biol. 15 (11): 947–54. doi:10.1089/dna.1996.15.947. PMID8945635.
Bützow R, Huhtala ML, Bohn H, etal. (1988). "Purification and characterization of placental protein 5". Biochem. Biophys. Res. Commun. 150 (1): 483–90. doi:10.1016/0006-291X(88)90546-3. PMID3276312.
Takayama M, Soma H, Saito T, etal. (1983). "Circulating levels of placental protein 5 in normal and abnormal pregnancies". Gynecol. Obstet. Invest. 16 (1): 13–26. doi:10.1159/000299207. PMID6884838.
Petersen LC, Sprecher CA, Foster DC, etal. (1996). "Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor". Biochemistry. 35 (1): 266–72. doi:10.1021/bi951501d. PMID8555184.
Miyagi Y, Yasumitsu H, Eki T, etal. (1996). "Assignment of the human PP5/TFPI-2 gene to 7q22 by FISH and PCR-based human/rodent cell hybrid mapping panel analysis". Genomics. 35 (1): 267–8. doi:10.1006/geno.1996.0353. PMID8661135.
Udagawa K, Miyagi Y, Hirahara F, etal. (1998). "Specific expression of PP5/TFPI2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization". Placenta. 19 (2–3): 217–23. doi:10.1016/S0143-4004(98)90011-X. PMID9548189.
Udagawa K, Yasumitsu H, Esaki M, etal. (2002). "Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts". Placenta. 23 (2–3): 145–53. doi:10.1053/plac.2001.0774. PMID11945080.
Rao CN, Segawa T, Navari JR, etal. (2003). "Methylation of TFPI-2 gene is not the sole cause of its silencing". Int. J. Oncol. 22 (4): 843–8. doi:10.3892/ijo.22.4.843. PMID12632077.